Hemp’s FDA Declassification Opens Door to Massive CBD Market Growth

NEW YORK, January 31, 2019 /PRNewswire/ —

FinancialBuzz.com News Commentary 

Cannabis is a family of plants that splits into two categories, marijuana and hemp. However, marijuana contains the psychoactive components of the plant while hemp has more practical uses such as clothing. Due to the effects of marijuana, it is currently more regulated as opposed to hemp. Hemp, being the non-psychoactive derivative of cannabis currently enjoys significantly less Federal regulations around the country, and, due to the current status of hemp, the industry is positioned to see significant growth. According to data compiled by Hemp Business Journal, a division of New Frontier Data, the U.S. hemp industry registered sales of USD 820 Million in 2017 and is expected to reach USD 1.9 Billion by 2022. Additionally, the market is projected to grow at a CAGR of 14.4% during the forecast period. Pressure BioSciences, Inc. (OTC: PBIO),

... read more at: https://www.prnewswire.com/news-releases/hemp-s-fda-declassification-opens-door-to-massive-cbd-market-growth-897133713.html